Vadlīniju pilns teksts

Literatūras atsauces:
1. Hancock BW, Newlands ES, Berkowitz RS, Chapman and Hall. Comprehensive
review of GTD. Gestational Trophoblastic Disease, 1997.
2. The Society of Gynecologic Oncologists’ Guidelines for referral to a gynaecologic
oncologist: Rationale and benefits: Trophoblastic disease. Gynecol Oncol 2000;78:S13.
3. Cole LA. Use of hCG tests for evaluating Trophoblastic Disease in Hancock et al.,
2002.
4. Cole LA, Sutton JM, Selecting an appropriate hCG test for managing gestational
trophoblastic disease and cancer. J Reprod Med. 2006;51:217.
5. Cole LA, Dai D, Leslie KK, Butler SA, Kohorn EI, Gestational trophoblastic
diseases: 1. Pathophysiology of hyperglycosylated hCG. Gynecol Oncol. 2006;102:145-50.
6. Cole LA, Butler SA, Khanlian SA, Giddings A, Muller CV, Seckl, MJ, Kohorn EI,
Gestational Trophoblastic Disease 2. Hyperglycosylated human Chorionic Gonadotropin
as a reliable Marker of Active Neoplasia. Gynec. Oncol. 2006; 102: 151-159.
7. Kohorn EI, McCarthy SM, Taylor KJW: Nonmetastatic Gestational Trophoblastic
Neoplasia. The Role of Ultrasonography and Magnetic Resonance Imaging. J. Reprod.
Med 43:14-20, 1998.
8. Ngan HYS, Benedet JL, Jones III HW, Bender HG, Pecorelli S.FIGO Staging and
Risk Factor Scoring for Trophoblastic Neoplasia. Int. J. Gynecol. Obstet. 77: 285 – 287,
2002.
9. Kohorn EI: Staging and Assessing Trophoblastic Tumours, a Possible Solution to
an Intractable Problem. J. Reprod. Med. 43: 33-36, 1998.
10. Kohorn EI: Evaluation of the criteria used to make the diagnosis of non-metastatic
gestational trophoblastic neoplasia. Gynecol Oncol 48:139-147, 1993.
11. Kohorn EI: The Trophoblastic Tower of Babel Classifications Systems for
Metastatic Gestational Trophoblastic Neoplasia. Gynecol Oncol 56:280-288, 1995.
12. Hancock BW, Welch EM, Gillespie AM, et al, (2000) A Retrospective comparison
of current and proposed staging and scoring systems for persistent gestational trophoblastic
disease. Int J Gynecol Cancer, 10: 318-322.
13. Kohorn EI, What we know about low-level hCG: definition, classification and
management. J Reprod Med. 2004;49:433-7.
14. Cole LA, Khanlian SA, Giddings A, Butler SA, Muller CY, Hammond C, Kohorn
EI, Gestational trophoblastic diseases: 4.
15. Presentation with persistent low positive human chorionic gonadotropin test results.
Gynecol Oncol. 2006;102:165-72.
16. Paradinas FJ, Pathology in Gestational Trophoblastic Disease. Hancock BW,
Newlands ES, Berkowitz RS. Chapman and Hall, 1997. pp 43-76.
109